Hong Mei

Hong Mei practices at MASS General Brigham Amsurg in Salem, New Hampshire.

Hong Mei's NPI, 1841473477, was assigned on December 5, 2007. Hong Mei graduated from Stanford University School of Medicine in 2006. Hong Mei holds Massachusetts license 240540.

Hong Mei's primary practice is MASS General Brigham Amsurg, at 30 Tuscan BLFD Fl 3, Salem, NH 03079. Hong Mei also practices at Mass General Brigham Amsurg Inc., 2 Tuscan Blvd, Salem, NH 03079.

Hong Mei's primary practice is MASS General Brigham Amsurg in Salem, New Hampshire. Hong Mei is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Hong Mei to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hong Mei practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Hong Mei's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Hong Mei's licenses on file in 2 states: Massachusetts and California.

CMS data shows 168 Medicare services from Hong Mei across 4 procedure codes in 2024, for 102 Medicare patients. Medicare paid $19,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Hong Mei in 2024. The largest group is 75 to 84, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hong Mei's median patient age at 77, with 61% women.

In 2024, Hong Mei wrote 22 Medicare Part D claims. 91% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $444 in total drug cost.

Hong Mei accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Hong Mei, published from 2014 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease and Brain. Hong Mei has published most often in ACS Med Chem Lett. Hong Mei's most frequent co-authors are Kelly Henrickson, MD, Jie He, MD and John T. Meredith, MD.

CMS Open Payments shows 2 general payments to Hong Mei from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $130.

Hong Mei graduated from Stanford University School of Medicine in 2006.